Acute myocardial infarction in a patient with Wolff-Parkinson-White syndrome

时间：2024-08-31

Xu-Gang TANG,Jing WEN,Xue-Sen ZHANG,Xiang-Jun LI, Da-Chun JIANG,#

Xu-Gang TANG1,*,Jing WEN2,*,Xue-Sen ZHANG1,Xiang-Jun LI3, Da-Chun JIANG1,#

1Department of Cardiology, No. 37 Hospital of PLA, Ya’an, Sichuan Province, China2Department of Pediatrics, People’s Hospital of Hechuan District, Chongqing, China3Department of Cardiology, No. 22 Hospital of PLA, Ge’ermu, Qinghai Province, China

J Geriatr Cardiol 2018; 15: 605608. doi:10.11909/j.issn.1671-5411.2018.09.010

Acute myocardial infarction; Amiodarone; Atrial fibrillation; Wolff-Parkinson-White syndrome

It is known that the Wolff-Parkinson-White syndrome (WPW) may either mimic myocardial infarction (MI) or mask the ECG changes of MI. Thus, the diagnosis of MI coexisting with WPW is frequently difficult. Furthermore, patients with WPW occurring acute MI may be life threatening. Therefore, early recognition and correct treatment allows rapid restoration of normal sinus rhythm and may decrease morbidity and mortality.

A 45-year-old male farmer was admitted to our hospital for five days of intermittent chest pain (pressure-like pain, less than ten minutes of time) with palpitations, associated closely with body work. He had no lung or gastrointestinal or neurological symptoms. He had undergone an intermittent and self-resolving palpitation from the past three years, with at least one or two episodes a week, diagnosed as WPW at other hospital. He took no medications, and had no family history. He was a nonsmoker and nondrinker, with no history documenting the presence of hypercholesterolemia, hypertension, and diabetes.

Physical examination was done. Blood pressure was 102/68 mm Hg, pulse was 211 beats/min, and arterial oxygen saturation was 98%. A 12-lead ECG showed a supraventricular tachycardia (Figure 1). Tachycardia was terminated by transesophageal atrial pacing (Figure 1S). However, tachycardia occurred 10 min later (Figure 2S). Intravenously amiodarone (0.15 g) was administered over a 10-min period. The heart rate decreased to between 150 and 180 beats/min. Seven minutes later, the farmer suddenly lost consciousness, involuntary twitching occurred in the hands and feet. Ventricular fibrillation was diagnosed on ECG monitor. The farmer was defibrillated successfully by a direct current precordial shock of 200 J (Figure 3S) and reverted into sinus rhythm.

Figure 1. Onset of supraventricular tachycardia. ECG was recorded at a paper speed of 25 mm/s and a gain of 10 mm/mV.

Troponin I taken after admission was significantly elevated at 5.78 ng/mL (reference threshold < 0.15 ng/mL). Cardiac enzymatic determinations showed increased serum lactic dehydrogenase (750 U/L, reference threshold < 245 U/L), creatine phosphukinase MB (37 U/L, reference threshold < 25 U/L), and glutamic oxalacetic transaminase (75 U/L, reference threshold < 37 U/L). The ECG showed a WPW pattern and the S-T segment elevation in leads V2through V4and the S-T segment depression in leads Ⅱ, Ⅲ, aVF, and V6(Figure 1S). An echocardiogramrevealed an enlargement of the left atrium (41 mm) and left ventricle (LVDd, 59 mm). Together, these data suggested that we were dealing with an MI of the anterior wall of the left ventricle.

Coronary angiography confirmed single vessel disease with 90% stenosis of the left anterior descending coronary artery, successfully treated with percutaneous coronary intervention (PCI) using a drug-eluting stent (Figure 2). The electrophysiology study also was performed after PCI. A left lateral anterior wall accessory pathway was documented, which was successfully ablated (15 Watt, 120 s) (Figure 3). Notably, atrial fibrillation was induced during electrophysiologic testing after the accessory pathway ablation (Figure 4S), and self resolved after the farmer sent back to the coronary care unit (Figure 5S).

He was discharged after nine days hospitalization, with free chest pain or palpitations. ECG taken after discharge three months showed a normal P-R interval and Q waves in leads V1through V4. The left atrium was 38 mm, and LVDd was 54 mm measured using ultrasonic cardiography.

Acute MI and WPW may present simultaneously, which is an emergent and potentially lethal event. Correct and timely diagnosis is critical for the effective control of this event. Here, we report a case of WPW with acute MI with multiple tachycardias occurring. Our study may be of help to doctors for clinical works.

Figure 2. Coronary angiography before (A) and after (B) percutaneous coronary intervention. Arrows indicating stenosis site.

Figure 3. Loss of pre-excitation during radiofrequency energy application.

Interestingly, the farmer was free of traditional cardiac risk factors, such as smoking habits, fat, hypercholesterolemia, hypertension, and diabetes, except for exposure to long working hours. The farmer was frequently working 9-11 hours a day, which may be the most possible risk factor for his acute MI according to the literatures.[1,2]Because of the existence of WPW, we initially couldn’t make a affirmative diagnosis of acute MI from the surface ECG (Figure 1 & 1S), although the greater ST-segment elevation in lead V1-V4 seemed unusual in the common form of type-A WPW syndrome. It is known that ECG may result in confusion when WPW and MI present simultaneously.[3,4]Thus, a misdiagnosis may be made on some conditions. Taking note of the newly occurring chest pain, we further tested the Troponin I and cardiac enzyme levels to exclude the potential cardiovascular diseases. With the significantly elevated Troponin I and cardiac enzyme levels, the farmer was highly suspected of suffering from an acute MI. The stenosis of the left anterior descending coronary artery was confirmed by coronary angiography (Figure 2). Given WPW and MI may have co-existed, we must take good care of WPW patients with new-onset chest pain, such as in our case, collapse,[5]syncope,[6]shock,[7]do not focus only on the surface ECG.

Patient of WPW with acute MI may occur multiple tachycardias.[8]In our case, the farmer suffered from supraventricular tachycardia (Figure 1), WPW with atrial fibrillation (Figure 2S), and ventricular fibrillation (Figure 3S) in a short time. Fortunately, he was defibrillated successfully by a direct current precordial shock. It is well known that both WPW and MI are closely associated with atrial fibrillation, and atrial fibrillation with a fast ventricular response may degenerate to catastrophic ventricular fibrillation, which is the most frequent cause (reason) of sudden cardiac death in WPW patients.[9,10]For stable patient of WPW with atrial fibrillation, intravenous procainamide is recommended,[11]however, this drug in our hospital is unavailable at that time. Amiodarone was initially used as an antianginal drug, which could increase coronary blood flow, and decrease myocardial oxygen consumption. Nowadays, amiodarone is widely used to control multiple arrhythmias in patients.[12,13]Guidelines gave the superiority of amiodarone in the use of antiarrhythmia in the stable WPW with atrial fibrillation patients.[14]However, some researchers argued against the superiority of administering amiodarone in WPW with atrial fibrillation patients because of the prodysrhythmic events in some cases.[15,16]Indeed, study didn’t show the same prodysrhythmic events in some other cases.[17]Therefore, the newly developed guideline indicates that intravenous amiodarone should be used with caution in WPW with atrial fibrillation patients.[18]In our case, intravenous amiodarone was suitable for control of rapid ventricular response in atrial fibrillation in the farmer with true MI according to the literatures.[12,18,19]It is well known that malignant dysrhythmia may happen to a patient with atrial fibrillation with fast ventricular response, acute MI, etc. Amiodarone should not be accounted for malignant arrhythmic events in the patient with WPW and atrial fibrillation due to the lack of well-designed studies now.

In conclusion, acute MI and WPW may present simultaneously. Urgent direct current cardioversion should be considered in unstable patients. Intravenous amiodarone should be used with caution in WPW with atrial fibrillation patients. Further study is needed for assessment of intravenous amiodarone for heart rate control in WPW with atrial fibrillation patients.

Acknowledgments

The authors are grateful to the participant for his participation in this paper. We declare that we have no conflict of interest.

1 Kivimäki M, Jokela M, Nyberg ST,. IPD-Work Consortium. Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603,838 individuals.2015; 386: 1739–1746.

2 Conway SH, Pompeii LA, Roberts RE,. Dose-response relation between work hours and cardiovascular disease risk: findings from the panel study of income dynamics.2016; 58: 221–226.

3 Astorri E, Pattoneri P. Wolff-Parkinson-White syndrome and myocardial infarction: a case report.2006; 108: 416–417.

4 Smolders L, Majidi M, Krucoff MW,. Preexcitation and myocardial infarction: conditions with confusing electrocardiographic manifestations.2008; 41: 679–682.

5 Beatson K, Khorsandi M, Grubb N. Wolff-Parkinson-White Syndrome and myocardial infarction in ventricular fibrillation arrest: a case of two one-eyed tigers.2013; 106: 755–757.

6 Butcovan D. Myocardial infarction in an individual with Wolff-Parkinson-White syndrome.2013; 21: 1–4.

7 Stein I, Wroblewski F. Myocardial infarction in Wolff-Parkinson-White syndrome.1951; 42: 624–630.

8 Ozaydín M, Varol E, Dogan A,. Multiple tachycardia forms occurring in a patient with Wolff-Parkinson-White syndrome and acute myocardial infarction.2007; 55: 427.

9 Pietersen AH, Andersen ED, Sandøe E. Atrial fibrillation in the Wolff-Parkinson-White syndrome.1992; 70: 38A–43A.

10 Priori SG, Aliot E, Blomstrom-Lundqvist C,. Task force on sudden cardiac death of the European Society of Cardiology.2001; 22: 1374–1450.

11 Fengler BT, Brady WJ, Plautz CU. Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the ED.2007; 25: 576–583.

12 Sasaki N, Watanabe I, Kogawa R,. Effects of intravenous amiodarone and ibutilide on action potential duration and atrial conduction kinetics in patients with persistent atrial fibrillation.2014; 55: 244–248.

13 Koike H, Fujino T, Koike M,Obesity is associated with the development of interstitial pneumonia under long-term administration of amiodarone in refractory atrial fibrillation patients.2016; 57: 30–34.

14 Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care (70-2041). The American Heart Association in collaboration with the International Liaison Committee on Resuscitation.2000; 102(8 Suppl): S136–S139.

15 Tijunelis MA, Herbert ME. Myth: intravenous amiodarone is safe in patients with atrial fibrillation and Wolff-Parkinson- White syndrome in the emergency department.2005; 7: 262–265.

16 Simonain SM, Lotfipour S, Wall C,. Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.2010; 5: 421–426.

17 Wellens HJ, Brugada P, Abdollah H,. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient.1984; 69: 120–124.

18 Kirchhof P, Benussi S, Kotecha D,. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016; 37: 2893–2962.

19 Barnett DB, Akhtar N, Hudson SA. Intravenous amiodarone in atrial fibrillation complicating myocardial infarction.() 1982; 284: 823–824.

*The two authors contributed equally to this work.

Correspondence to:jdc_37@163.com